Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8. Background: Earlier trials of ...

Among mild to moderately symptomatic heart-failure patients with impaired LVEF, initiation of treatment with bisoprolol followed by enalapril, as compared with the opposite sequence of drugs ...

Congestive heart failure (CHF) affects approximately 4 million individuals in the United States with 500,000 new cases diagnosed each year. [1] Previously, beta-blockers were absolutely ...

Beta blockers are medications commonly used for treating cardiac problems such as high blood pressure, chest pain, irregular heartbeat and heart failure. In the US, for example, one in five adults ...

I (f) Channel Blockers An I (f) channel blocker such as Corlanor (ivabradine) is another option for managing CHF, usually when beta blockers don't fully control heart rate.

HEART FAILURE Beta blockers seem safe, even in the initial weeks of treatment. * THE QUESTION Do beta blocker drugs endanger patients' lives before producing beneficial effects?

(Image: Express.co.uk) The participants were tracked for an average of four and a half years. None of them had heart failure but 34,253 were still taking beta blockers a year after being discharged.

Around 60,000 people are prescribed beta blockers every year in the UK. But a trial has found that, for about half of patients, they do not reduce the risk of death or further heart attacks.

It ran from 2018 to 2023 and involved 806 patients who had had a heart attack but no problems with heart failure. Half were given beta blockers and the other half were not.

One way or another, beta blockers are always in the news. Take, for instance, Los Angeles Chargers Head Coach Jim Harbaugh, who revealed in October that he's part of a growing group of Americans ...

The study ran from 2018 to 2023. "Beta blocker treatment led to a modest increase in depressive symptoms" for heart attack survivors who weren't in heart failure, the researchers reported.

The study ran from 2018 to 2023. "Beta blocker treatment led to a modest increase in depressive symptoms" for heart attack survivors who weren't in heart failure, the researchers reported.